Viewing Study NCT00079066


Ignite Creation Date: 2025-12-24 @ 4:12 PM
Ignite Modification Date: 2026-02-02 @ 6:22 PM
Study NCT ID: NCT00079066
Status: COMPLETED
Last Update Posted: 2023-08-04
First Post: 2004-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Sponsor: NCIC Clinical Trials Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: CO17
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View